ECM
DPLO

ETrade Capital Management’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

ETrade Capital Management’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-8,601
Closed -$220K – 864
2018
Q2 		$220K Buy
+8,601
New +$201K 0.01% 741
2018
Q1 		– Sell
-13,768
Closed -$276K – 788
2017
Q4 		$276K Buy
+13,768
New +$271K 0.01% 643

Other funds holding DPLO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return

ETrade Capital Management's DPLO Position: Q3 2018 in Review

ETrade Capital Management sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q3 2018, closing a stake of 8,601 shares — an estimated $220K sold.

ETrade Capital Management first reported a position in DPLO in Q4 2017 and held it in 2 quarters. The position peaked at $276K in Q4 2017. 178 funds tracked by Wall St. Rank hold DPLO as of Q3 2018.

  • ETrade Capital Management reported no remaining DIPLOMAT PHARMACY, INC. position as of Q3 2018 after selling out during the quarter.
  • ETrade Capital Management sold 8,601 DIPLOMAT PHARMACY, INC. shares in Q3 2018, an estimated $220K.
  • ETrade Capital Management first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2017 and held it in 2 quarters.
  • ETrade Capital Management's DIPLOMAT PHARMACY, INC. position peaked at $276K in Q4 2017.
  • 178 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q3 2018.

Based on ETrade Capital Management's 13F filing for Q3 2018, filed 14 Nov 2018.